首页> 外文期刊>Biological psychiatry >Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: Late-onset psychotic clinical presentation
【24h】

Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: Late-onset psychotic clinical presentation

机译:C9ORF72六核苷酸重复扩增导致常染色体显性额颞叶变性:迟发性精神病临床表现

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: A hexanucleotide repeat expansion in the first intron of C9ORF72 has been shown to be responsible for a high number of familial cases of amyotrophic lateral sclerosis or frontotemporal lobar degeneration (FTLD). Atypical presentations have been described, particularly psychosis. Methods: We determined the frequency of the hexanucleotide repeat expansions in a population of 651 FTLD patients and compared the clinical characteristics of carriers and noncarriers. In addition, we genotyped 21 patients with corticobasal syndrome, 31 patients with progressive supranuclear palsy, and 222 control subjects. Results: The pathogenic repeat expansion was detected in 39 (6%) patients with FTLD (17 male and 22 female subjects); however, it was not detected in any corticobasal syndrome and progressive supranuclear palsy patients or controls. Twenty-four of 39 carriers had positive family history for dementia and/or amyotrophic lateral sclerosis (61.5%), whereas only 145 of 612 noncarriers had positive family history (23.7%; p<.000001). Clinical phenotypes of carriers included 29 patients with the behavioral variant frontotemporal dementia (bvFTD; 5.2% of all bvFTD cases), 8 with bvFTD/motor neuron disease (32% bvFTD/motor neuron disease cases), 2 with semantic dementia (5.9% of patients with semantic dementia), and none with progressive nonfluent aphasia. The presentation with late-onset psychosis (median age = 63 years) was more frequent in carriers than noncarriers (10/33 vs. 3/37, p =.029), as well as the presence of cognitive impairment at onset (15/33 vs. 5/37; p =.0039). Conclusions: The repeat expansion in C9ORF72 is a common cause of FTLD and often presents with late-onset psychosis or memory impairment.
机译:背景:C9ORF72的第一个内含子中的六核苷酸重复扩增已被证明与许多肌萎缩性侧索硬化或额颞叶变性(FTLD)家族病例有关。已经描述了非典型表现,特别是精神病。方法:我们确定了651名FTLD患者人群中六核苷酸重复扩增的频率,并比较了携带者和非携带者的临床特征。此外,我们对21例肾上腺皮质综合征,31例进行性核上性麻痹患者和222例对照受试者进行了基因分型。结果:39例(6%)FTLD患者(17例男性和22例女性)中发现了病原体重复扩增;但是,在任何皮质基底肌综合征和进行性核上性麻痹患者或对照中均未检出。 39名携带者中有24名患有痴呆和/或肌萎缩性侧索硬化症的家族史为阳性(61.5%),而612名非携带者中只有145名家族史为阳性(23.7%; p <.000001)。携带者的临床表型包括29例行为变异性额颞叶痴呆患者(bvFTD;占所有bvFTD病例的5.2%),8例bvFTD /运动神经元疾病(32%的bvFTD /运动神经元疾病),2例语义性痴呆(占5.9%患有语义性痴呆的患者),没有进行性非流利性失语症的患者。携带迟发性精神病(中位年龄= 63岁)的患病率高于非携带者(10/33 vs. 3/37,p = .029),以及发病时存在认知障碍(15 / 33比5/37; p = .0039)。结论:C9ORF72的重复扩增是FTLD的常见原因,通常表现为迟发性精神病或记忆障碍。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号